Your browser doesn't support javascript.
loading
Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice.
Kedaigle, Amanda J; Reidling, Jack C; Lim, Ryan G; Adam, Miriam; Wu, Jie; Wassie, Brook; Stocksdale, Jennifer T; Casale, Malcolm S; Fraenkel, Ernest; Thompson, Leslie M.
Afiliación
  • Kedaigle AJ; Computational and Systems Biology Program.
  • Reidling JC; Memory Impairment and Neurological Disorders Research Unit.
  • Lim RG; Memory Impairment and Neurological Disorders Research Unit.
  • Adam M; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
  • Wu J; Memory Impairment and Neurological Disorders Research Unit.
  • Wassie B; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
  • Stocksdale JT; Memory Impairment and Neurological Disorders Research Unit.
  • Casale MS; Memory Impairment and Neurological Disorders Research Unit.
  • Fraenkel E; Computational and Systems Biology Program.
  • Thompson LM; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Hum Mol Genet ; 29(2): 202-215, 2020 01 15.
Article en En | MEDLINE | ID: mdl-31696228

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Azepinas / Triazoles / Corteza Cerebral / Enfermedad de Huntington / Cuerpo Estriado / Proteína Huntingtina Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Hum Mol Genet Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Azepinas / Triazoles / Corteza Cerebral / Enfermedad de Huntington / Cuerpo Estriado / Proteína Huntingtina Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Hum Mol Genet Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2020 Tipo del documento: Article